- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05320913
Pericapsular Nerve Group (PENG) Block Combined With Periarticular Multimodal Drug Injection (PMDI) Versus Isolated PMDI for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial
May 2, 2022 updated by: Yonsei University
Adequate pain control after total hip arthroplasty is crucial for early ambulation and patient satisfaction.
However, there is no consensus about optimal pain control after post operation.
In general, the periarticular multimodal durg injection block has been done for pain control in primary total hip arthroplasty.
The pericapsular nerve group (PENG) block has been recently introduced a new technique for blockade of the articular branches of the femoral, obturator and accessory obturator nerves.
PENG block is possible to provide sufficient analgesia and preserve lower limb muscle strength.
The investigators will compare PENG and PMDI block with isolated PMDI block in patients undergoing total hip arthroplasty.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Anticipated)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kwankyu Park
- Phone Number: 82-2-2228-2183
- Email: kkpark@yuhs.ac
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Yonsei University Health system, Severance Hospital
-
Contact:
- Kwankyu Park
- Phone Number: 82-2-2228-2183
- Email: kkpark@yuhs.ac
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
1. Patients aged 19 years old or older, with American Society of Anesthesiologists Physical Status 1-3, and scheduled for elective unilateral total hip arthroplasty
Exclusion Criteria:
- Allergy or intolerance to any of the drugs used in the study
- Hepatic or renal insufficiency
- Opioid dependency
- Coagulopathy
- Pre-existing neurologic or anatomic deficits in the lower extremities
- Severe psychiatric illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pericapsular nerve group(PENG) block combined with periarticular multimodal drug injection (PMDI)
Participants receiving pericapsular nerve group(PENG) block combined with periarticular multimodal drug injection (PMDI)
|
periarticular local anesthetic infiltration with 120 mg of ropivacaine, epinephrine 0.2 mg and 30 mg of ketorolac diluted with normal saline to a total volume of 40 mL.
+ PENG block with ropivacaine 40 mg and epinephrine 0.1 mg with normal saline to a total volume of 20 mL
Other Names:
|
Active Comparator: isolated periarticular multimodal drug injection (PMDI)
Arm Description: Participants receiving isolated periarticular multimodal drug injection (PMDI)
|
periarticular local anesthetic infiltration with 150 mg of ropivacaine, epinephrine 0.3 mg and 30 mg of ketorolac diluted with normal saline to a total volume of 50 mL
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numeric rating scale pain score
Time Frame: at 24 hours postoperatively
|
Pain intensity at rest evaluated by an 11-point numeric rating scale (NRS: 0 = no pain, 10 = worst imaginable pain) at 24 hours postoperatively
|
at 24 hours postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain score measured at 6 hours postoperatively and 48 hours postoperatively
Time Frame: Pain score measured at 6 hours postoperatively and 48 hours postoperatively
|
Pain intensity at rest evaluated by an 11-point numeric rating scale (NRS: 0 = no pain, 10 = worst imaginable pain) at 6 hours postoperatively and 48h postoperatively
|
Pain score measured at 6 hours postoperatively and 48 hours postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kwankyu Park, Department of orthopaedic surgery, Yonsei University College of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 4, 2022
Primary Completion (Anticipated)
December 13, 2023
Study Completion (Anticipated)
December 13, 2023
Study Registration Dates
First Submitted
April 3, 2022
First Submitted That Met QC Criteria
April 8, 2022
First Posted (Actual)
April 11, 2022
Study Record Updates
Last Update Posted (Actual)
May 3, 2022
Last Update Submitted That Met QC Criteria
May 2, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2021-1482
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Hip Arthroplasty, Postoperative Pain
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
-
Yonsei UniversityCompletedPostoperative Pain | Total Hip ArthroplastyKorea, Republic of
-
Sylvia WilsonCompletedPostoperative Pain | Total Hip ArthroplastyUnited States
-
Marmara UniversityActive, not recruitingPostoperative Pain | Total Hip ArthroplastyTurkey
-
Kresimir Oremus, MDCompletedPostoperative Pain | Total Hip ArthroplastyCroatia
-
Yonsei UniversityCompletedPostoperative Pain | Total Hip ArthroplastyKorea, Republic of
-
Loma Linda UniversityCharles Lee MD; Michelle Schlunt MDWithdrawnPostoperative Pain Management After Total Hip Arthroplasty
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
Clinical Trials on Pericapsular nerve group(PENG) block combined with periarticular multimodal drug injection (PMDI)
-
Cairo UniversityRecruiting
-
Yonsei UniversityCompletedPostoperative Pain | Total Hip ArthroplastyKorea, Republic of
-
Ospedale Edoardo BassiniNot yet recruitingRegional Anesthesia | Regional Anesthesia Block | Total Hip Replacement Surgery | Total Hip Arthroplasty \(THA\)
-
Hanoi Medical UniversityCompletedPOSTOPERATIVE ANALGESIAVietnam
-
Orange Park Medical CenterNot yet recruitingAnalgesia | Hip Fractures | Nerve Block
-
University Hospital, AntwerpCompletedPain, Postoperative | Arthroplasty, Replacement, Hip | Anesthesia, ConductionBelgium
-
Fayoum University HospitalRecruiting
-
Aydin Adnan Menderes UniversityRecruiting